article thumbnail

Cosette Pharmaceuticals Acquires Mayne Pharma

The Dermatology Digest

Cosette Pharmaceuticals, Inc. Upon close, Cosette will market 12 patent-protected products focused on womens health and dermatology, including leading brands such as Rhofade (oxymetazoline topical)and several programs in clinical development. is acquiring Mayne Pharma. share for a total consideration of approximately USD $430 Million.

article thumbnail

Why Not All Olive Oils Are Created Equal And How to Choose the Best

Alison Bladh

The Truth About Olive Oil Quality Olive oil is often marketed as a "healthy fat," but what many people dont realise is that the quality can vary dramatically. How to Spot High-Quality Olive Oil With so many olive oils on the market, how do you ensure youre getting the best? Current Pharmaceutical Design , 17(8), pp.754768.

Diet 97
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Smart fabric converts body energy into electricity 

Spa Executive

.” Li, director of Waterloo’s Printable Electronic Materials Lab, said in a statement: “AI technology is evolving rapidly, offering sophisticated signal analysis for health monitoring, food and pharmaceutical storage, environmental monitoring, and more. Another example is 3DKnITS, developed by MIT researchers.

article thumbnail

Derm-Biome Adds Dr. Jerry Tan to Its Scientific Advisory Board

The Dermatology Digest

Jerry Tan, MD, is joining Derm-Biome Pharmaceuticals, Inc.’s The acne market is changing, as consumers seek safer and more natural topical alternatives that offer faster results with low irritation. We have developed a product that we feel can help address that changing market need.” s Scientific Advisory Board.

article thumbnail

Biosimilar News: Selarsdi Scores FDA Approval for Interchangeability With Stelara

The Dermatology Digest

FDA has approved Teva Pharmaceuticals and Alvotechs Selarsdi injection, a biosimilar to Stelara ((ustekinumab), as an interchangeable treatment for inflammatory conditions. ” Interchangeability of SELARSDI with Stelara will further enable increased access for U.S. With two important biosimilars on the U.S. in May 2024.

article thumbnail

There Are So Many Skincare Lines– Is One Better Than Another?

Renee Rouleau

In today’s saturated skincare market, it can be overwhelming to navigate through the countless options available. Pharmaceutical and Medical Advancements Ingredients that have been traditionally used for non-skincare purposes are now finding their way into the beauty industry. This is a fair point.

Skincare 195
article thumbnail

Multi-Mechanical Therapies with Topicals For Age Management

Lipgloss and Aftershave

Phyllis Hsieh is the visionary behind Conrex Pharmaceutical Corp. Under her leadership, SESHA has expanded into a diverse range of over 70 therapeutic products, now available across Asia, Europe, and other global markets. The Permeation Enhancement Technology is FDA-approved in pharmaceuticals.